Danish Evaluation of Your Heart Forecast.
DANY
1 other identifier
interventional
600
1 country
1
Brief Summary
Under 50% of patients diagnosed with hypertension and treated in general practice, have reached a blood pressure within the recommended levels of the national guideline. Compliance is the main problem for these patients, but effective tools for increasing patient compliance are missing. The objective is to evaluate the risk-assessment and risk-communication tool: "Your Heart Forecast", to see if it can improve patient compliance, health literacy and empowerment. Patients will be followed in a cluster-randomised controlled trial in the setting of general practice, using surveys at inclusion and after 6 and 12 months. Besides surveys, the participants' blood pressure will be measured as a hard outcome and data will be drawn from various patient databases. After 6 months, qualitative interviews will be conducted, with a subgroup of patients from the intervention group. It is expected to find whether the use of Your Heart Forecast can lower patients' blood pressure and/or increase their compliance, health literacy and empowerment. The aim is to show if an increase in general health literacy and patient empowerment, as measured by Patient Activation Measure(PAM13) can be seen. The investigators hope to reveal whether this software can improve patient compliance and thereby be a reasonable tool to implement in the national blood pressure control program. In further studies, it should be shown if the cost of using this program is far less than expenses for hospitalisation due to complications and comorbidity to hypertension.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 26, 2018
CompletedStudy Start
First participant enrolled
March 27, 2019
CompletedFirst Posted
Study publicly available on registry
August 16, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedMay 23, 2022
May 1, 2022
3.5 years
October 26, 2018
May 20, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Health literacy
Self-reported change in health literacy through questionnaires.
Questionnaire sent out at inclusion, after 6 months and after 1 year
Secondary Outcomes (4)
Blood pressure
Calculated after the 1 year trial period
Adherence
Questionnaire sent out at inclusion, after 6 months and after 1 year
Empowerment
Questionnaire sent out at inclusion, after 6 months and after 1 year
Number of contacts
Counted after end of 1 year trial period.
Study Arms (2)
Intervention
EXPERIMENTALUse of Your Heart Forecast and an e-mail follow up-program.
Control
NO INTERVENTIONThe control group uses standard regime (business as usual).
Interventions
1 year follow up with Your Heart Forecast and a follow-up email every 2 weeks.
Eligibility Criteria
You may qualify if:
- All patients must understand and read Danish and must be cognitively well functioning.
- The patient must have Internet access, host an email address and read their emails on regular basis (at least once a week).
- All included patients must be diagnosed with hypertension and go to regular blood pressure control consultations at their GP (at least once a year).
- Both patients with known hypertension and those newly discovered are accepted into the trial.
- Age from 35 to 75 years (both included).
- Both genders are included.
You may not qualify if:
- If the patient during the trial develops prolonged illness so severe that treatment of hypertension is no longer a priority, he/she will be excluded.
- Patients with blood pressure above 170/100 are excluded, as these patients should receive intensive blood pressure treatment regardless of their predicted CVD risk or heart age.
- Pregnancy.
- Very high cholesterol (TCL or TCL/HDL 8 or over).
- Genetic lipid disorders.
- If the patient is diabetic AND has a complicating kidney disease.
- Known problems with arteries to the legs defined as:
- Clinical symptoms of claudication
- Diminished foot pulses
- Carotid bruits
- Radiological evidence
- Prior surgery /percutaneous interventions
- Prior stroke or mini-stroke (TIA).
- Angina, prior AMI or heart related operation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Southern Denmarklead
- Region of Southern Denmarkcollaborator
- Odense Patient Data Explorative Networkcollaborator
- ENIGMA Solutions Limitedcollaborator
- Lilly & Herbert Hansens Foundationcollaborator
- The A. P. Møller and Chastine McKinney Møller Foundationcollaborator
Study Sites (1)
Research Unit of General Practice, Department of Public Health, University of Southern Denmark
Odense, Region Syddanmark, 5000, Denmark
Related Publications (14)
Reuther LO, Paulsen MS, Andersen M, Schultz-Larsen P, Christensen HR, Munck A, Larsen PV, Damsgaard J, Poulsen L, Hansen DG, Christensen B, Sondergaard J. Is a targeted intensive intervention effective for improvements in hypertension control? A randomized controlled trial. Fam Pract. 2012 Dec;29(6):626-32. doi: 10.1093/fampra/cms031. Epub 2012 May 7.
PMID: 22565110BACKGROUNDSoureti A, Hurling R, Murray P, van Mechelen W, Cobain M. Evaluation of a cardiovascular disease risk assessment tool for the promotion of healthier lifestyles. Eur J Cardiovasc Prev Rehabil. 2010 Oct;17(5):519-23. doi: 10.1097/HJR.0b013e328337ccd3.
PMID: 20195154BACKGROUNDPedersen KM, Andersen JS, Sondergaard J. General practice and primary health care in Denmark. J Am Board Fam Med. 2012 Mar;25 Suppl 1:S34-8. doi: 10.3122/jabfm.2012.02.110216.
PMID: 22403249BACKGROUNDBrust-Renck PG, Royer CE, Reyna VF. Communicating Numerical Risk: Human Factors That Aid Understanding in Health Care. Rev Hum Factors Ergon. 2013 Oct;8(1):235-276. doi: 10.1177/1557234X13492980.
PMID: 24999307BACKGROUNDBerkman ND, Sheridan SL, Donahue KE, Halpern DJ, Crotty K. Low health literacy and health outcomes: an updated systematic review. Ann Intern Med. 2011 Jul 19;155(2):97-107. doi: 10.7326/0003-4819-155-2-201107190-00005.
PMID: 21768583BACKGROUNDWells S, Kerr A, Eadie S, Wiltshire C, Jackson R. 'Your Heart Forecast': a new approach for describing and communicating cardiovascular risk? Heart. 2010 May;96(9):708-13. doi: 10.1136/hrt.2009.191320. No abstract available.
PMID: 20424153BACKGROUNDDe Geest S, Sabate E. Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs. 2003 Dec;2(4):323. doi: 10.1016/S1474-5151(03)00091-4. No abstract available.
PMID: 14667488BACKGROUNDMaindal HT, Sokolowski I, Vedsted P. Translation, adaptation and validation of the American short form Patient Activation Measure (PAM13) in a Danish version. BMC Public Health. 2009 Jun 29;9:209. doi: 10.1186/1471-2458-9-209.
PMID: 19563630BACKGROUNDSorensen K, Pelikan JM, Rothlin F, Ganahl K, Slonska Z, Doyle G, Fullam J, Kondilis B, Agrafiotis D, Uiters E, Falcon M, Mensing M, Tchamov K, van den Broucke S, Brand H; HLS-EU Consortium. Health literacy in Europe: comparative results of the European health literacy survey (HLS-EU). Eur J Public Health. 2015 Dec;25(6):1053-8. doi: 10.1093/eurpub/ckv043. Epub 2015 Apr 5.
PMID: 25843827BACKGROUNDPerestelo-Perez L, Rivero-Santana A, Boronat M, Sanchez-Afonso JA, Perez-Ramos J, Montori VM, Serrano-Aguilar P. Effect of the statin choice encounter decision aid in Spanish patients with type 2 diabetes: A randomized trial. Patient Educ Couns. 2016 Feb;99(2):295-9. doi: 10.1016/j.pec.2015.08.032. Epub 2015 Sep 1.
PMID: 26343571BACKGROUNDProchaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997 Sep-Oct;12(1):38-48. doi: 10.4278/0890-1171-12.1.38.
PMID: 10170434BACKGROUNDMadsbad S, Larsen ML, Adeler HF, Kryhlmand M, Westergaard M. [Implementation of clinical guidelines in general practice. The effect of journal audit and continuing education for the treatment of cardiovascular risk factors in patients with and without type 2 diabetes]. Ugeskr Laeger. 2006 Apr 24;168(17):1640-5. Danish.
PMID: 16674875BACKGROUNDStjernholm K, Andersen HS, Jensen AE, Nielsen JB. Danish evaluation of Your Heart Forecast: a cluster randomised controlled trial aimed at improving modifiable risk factors of CVD. Open Heart. 2026 Jan 28;13(1):e003812. doi: 10.1136/openhrt-2025-003812.
PMID: 41605571DERIVEDJensen AE, Sondergaard J, Kjaer NK, Jackson R, Nielsen JB. Danish Evaluation of Your Heart Forecast (DANY): study protocol for a cluster randomised controlled trial on an interactive risk-communication tool aimed at improving adherence of patients with high blood pressure. Trials. 2020 Jan 3;21(1):11. doi: 10.1186/s13063-019-3886-2.
PMID: 31900231DERIVED
Study Officials
- STUDY CHAIR
Jesper B Nielsen, Professor, PhD
Research Unit of General Practice, University of Southern Denmark
- PRINCIPAL INVESTIGATOR
Anders E Jensen, M.D.
Research Unit of General Practice, University of Southern Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical doctor, Principal Investigator
Study Record Dates
First Submitted
October 26, 2018
First Posted
August 16, 2019
Study Start
March 27, 2019
Primary Completion
October 1, 2022
Study Completion
December 31, 2022
Last Updated
May 23, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share
Data from the project is only intended to be shared by publishing anonymised results.